Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from a physician concerning a 11 year old female patient with a history of positive for lyme disease who on 29-SEP-2009, was vaccinated with the first dose of GARDASIL (lot # 562300/0100Y, expiration date: 19-APR-2011) (dose and site of administration not reported) and in December 2009, the patient was vaccinated with the second dose of GARDASIL (lot number, dose and site of administration not reported). Concomitant therapy included cyproheptadine hydrochloride and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid vaccine. On unspecified date, the patient started experiencing migraines after GARDASIL administration which then subsided after a month and came back after a second dose in December 2009. The patient sought unspecified medical attention. No treatment was given for the treatment of the adverse event. At the time of the report, the patient had not recovered. Follow up information has been received from a health care professional concerning the female student patient with no pre-existing allergies, birth defects, medical conditions or illness at time of vaccination who on 01-DEC-2009, at 16:03, was vaccinated intramuscularly with the second dose of GARDASIL (lot number: 662724/0313Y). On 06-OCT-2009, at 14:57, the patient experienced migraines. At the time of this report, migraines were ongoing. Laboratories and a computed axial tomography were recommended. The patient was also referred with a neurologist. The patient sought unspecified medical attention. Migraines were considered to be disabling by the reporter. Additional information has been requested.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166